Skip to main content
SpringerLink
Log in

Outcomes of patients awaiting lung transplantation after the implementation of donation after brain death at a single Chinese center

  • Research Article
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Voluntary contribution has become the only source of donor lungs in China since 2015. To elaborate the outcomes of patients awaiting lung transplantation (LTx) after the implementation of donation after brain death, we performed a retrospective study that encompassed 205 patients with end-stage lung disease who registered for LTx at Shanghai Pulmonary Hospital from January 1, 2015 to January 1, 2021. A total of 180 patients were enrolled in the study. The median waiting time was 1.25 months. Interstitial lung disease (ILD) (103/180, 57.2%) and chronic obstructive pulmonary disease (COPD) (56/180, 31.1%) were the most common diseases in our study population. The mean pulmonary artery pressure (mPAP) of patients in the died-waiting group was higher than that of the survivors (53.29±21.71 mmHg vs. 42.11±18.58 mmHg, P=0.002). The mortality of patients with ILD (34/103, 33.00%) was nearly twice that of patients with COPD (10/56, 17.86%) while awaiting LTx (P=0.041). In the died-waiting group, patients with ILD had a shorter median waiting time than patients with COPD after being listed (0.865 months vs. 4.720 months, P=0.030). ILD as primary disease and mPAP > 35 mmHg were two significant independent risk factors for waitlist mortality, with hazard ratios (HR) of 3.483 (95% CI 1.311–9.111; P=0.011) and 3.500 (95% CI 1.435–8.536; P=0.006). Hence, LTx is more urgently needed in patients with ILD and pulmonary hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Valapour M, Skeans MA, Heubner BM, Smith JM, Hertz MI, Edwards LB, Cherikh WS, Callahan ER, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2013 Annual Data Report: lung. Am J Transplant 2015; 15(Suppl 2): 1–28

    Article  PubMed  Google Scholar 

  2. Chambers DC, Cherikh WS, Goldfarb SB, Hayes D Jr, Kucheryavaya AY, Toll AE, Khush KK, Levvey BJ, Meiser B, Rossano JW, Stehlik J; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation. J Heart Lung Transplant 2018; 37(10): 1169–1183

    Article  PubMed  Google Scholar 

  3. Huang J, Millis JM, Mao Y, Millis MA, Sang X, Zhong S. Voluntary organ donation system adapted to Chinese cultural values and social reality. Liver Transpl 2015; 21(4): 419–422

    Article  PubMed  Google Scholar 

  4. He WX, Yang YL, Xia Y, Song N, Liu M, Zhang P, Fan J, Jiang GN. Outcomes of Chinese patients with end-stage pulmonary disease while awaiting lung transplantation: a single-center study. Chin Med J (Engl) 2016; 129(1): 3–7

    Article  Google Scholar 

  5. Weill D. Lung transplantation: indications and contraindications. J Thorac Dis 2018; 10(7): 4574–4587

    Article  PubMed  PubMed Central  Google Scholar 

  6. Huang J, Wang H, Fan ST, Zhao B, Zhang Z, Hao L, Huo F, Liu Y. The national program for deceased organ donation in China. Transplantation 2013; 96(1): 5–9

    Article  PubMed  Google Scholar 

  7. Sun R. A study of cadaveric organ donation in China. J Sichuan Univ (Medical Science Edition) (Sichuan Da Xue Xue Bao Yi Xue Ban) 2014; (24): 47–53 (in Chinese)

  8. Allison KC, Caplan A, Shapiro ME, Els C, Paul NW, Li H. Historical development and current status of organ procurement from death-row prisoners in China. BMC Med Ethics 2015; 16(1): 85

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zhou J. A survey on factors affecting the general public’s willingness towards cadaveric organ donation in Guangzhou. Chin Med Ethics (Zhongguo Yi Xue Lun Li Xue) 2004; 17: 40–45 (in Chinese)

    Google Scholar 

  10. Wu Y, Elliott R, Li L, Yang T, Bai Y, Ma W. Cadaveric organ donation in China: a crossroads for ethics and sociocultural factors. Medicine (Baltimore) 2018; 97(10): e9951

    Article  Google Scholar 

  11. Shi BY. Development status of organ transplantation in China: the report on the 2018 Annual Meeting of Organ Transplantation of Chinese Medical Association. Organ Transplant (Qi Guan Yi Zhi) 2019; 10(1):32–35 (in Chinese)

    Google Scholar 

  12. China Organ Transplantation Development Foundation. Report on organ transplantation development in china (2015-2018). https://en.cma.org.cn/art/2020/5/14/art_692_34498.html (accessed April 4, 2022)

  13. D’Cunha HC, Rojas M. Ex vivo lung perfusion: past, present, and future. ASAIO J 2018; 64(2): 135–139

    Article  PubMed  Google Scholar 

  14. Arcasoy SM, Christie JD, Pochettino A, Rosengard BR, Blumenthal NP, Bavaria JE, Kotloff RM. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001; 120(3): 873–880

    Article  CAS  PubMed  Google Scholar 

  15. Paik HC, Haam SJ, Lee DY, Yi GJ, Song SW, Kim YT, Kang CH, Kim KM, Park SI, Jheon SH. The fate of patients on the waiting list for lung transplantation in Korea. Transplant Proc 2012; 44(4): 865–869

    Article  CAS  PubMed  Google Scholar 

  16. Kistler KD, Nalysnyk L, Rotella P, Esser D. Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature. BMC Pulm Med 2014; 14: 139

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wang L, Zhao QH, Pudasaini B, Jiang R, Gong SG, He J, Yuan P, Liu JM. Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China. Clin Respir J 2018; 12(3): 915–921

    Article  PubMed  Google Scholar 

  18. Gottlieb J. Lung allocation. J Thorac Dis 2017; 9(8): 2670–2674

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gottlieb J, Smits J, Schramm R, Langer F, Buhl R, Witt C, Strueber M, Reichenspurner H. Lung transplantation in Germany since the introduction of the lung allocation score. Dtsch Arztebl Int 2017; 114(11): 179–185

    PubMed  PubMed Central  Google Scholar 

  20. Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantation in the United States. J Heart Lung Transplant 2016; 35(4): 433–439

    Article  PubMed  Google Scholar 

  21. Tang A, Thuita L, Siddiqui HU, Rappaport J, Blackstone EH, McCurry KR, Ahmad U; Lung Transplantation Center. Urgently listed lung transplant patients have outcomes similar to those of electively listed patients. J Thorac Cardiovasc Surg 2020; [Epub ahead of print] doi: https://doi.org/10.1016/j.jtcvs.2020.02.140

Download references

Acknowledgements

This work was supported by the grants from the National Natural Science Foundation of China (Nos. 81100061 and 81670089), the Shanghai Municipal Commission of Health and Family Planning (No. 201640225), the Science and Technology Commission of Shanghai Municipality (No. 19411964100), and the Startup Fund for scientific research, Fujian Medical University (No. 2019 QH1278).

Author information

Author notes

  1. These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200092, China

    Yuling Yang, Xinnan Xu, Ming Liu, Yanfeng Zhao, Yongmei Yu, Xiaogang Liu, Chang Chen, Gening Jiang & Wenxin He

  2. Department of Cardiothoracic Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, China

    Yuling Yang

Authors
  1. Yuling Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xinnan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ming Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanfeng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yongmei Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaogang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gening Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wenxin He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wenxin He.

Ethics declarations

Yuling Yang, Xinnan Xu, Ming Liu, Yanfeng Zhao, Yongmei Yu, Xiaogang Liu, Chang Chen, Gening Jiang, and Wenxin He declared no conflicts of interest. This study was approved by the Ethics Committee of the Shanghai Pulmonary Hospital of Tongji University.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Xu, X., Liu, M. et al. Outcomes of patients awaiting lung transplantation after the implementation of donation after brain death at a single Chinese center. Front. Med. 16, 760–765 (2022). https://doi.org/10.1007/s11684-021-0899-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-021-0899-5

Keywords

Search

Navigation